Immunothérapie par transplantation de cellules souches hématopoïétiques allogéniques : actualités et perspectives

Future prospects and projects. - In addition to its established efficacy in hematological malignancies, several arguments are in favor of the use of allo-SCT in neoplastic solid tumors. Promising results from advanced cancer patients were already obtained. The present experience shows clearly that the allo-SCT strategy should be developed and refined because of the potential benefit that can be expected in some patients' sub-groups.